Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CPN-R.BK Stock Summary
Top 10 Correlated ETFs
CPN-R.BK
In the News
CPN-R.BK Financial details
Company Rating
Strong Buy
Market Cap
286.11B
Income
15.06B
Revenue
46.14B
Book val./share
20.56
Cash/share
1.13
Dividend
1.15
Dividend %
1.74%
Employees
-
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
21.26
Forward P/E
16.64
PEG
5.26
P/S
6.89
P/B
3.34
P/C
55.97
P/FCF
16.31
Quick Ratio
0.15
Current Ratio
0.44
Debt / Equity
0.86
LT Debt / Equity
0.4
-
-
EPS (TTM)
3.37
EPS next Y
3.8
EPS next Q
0.74
EPS this Y
40%
EPS next Y
12.86%
EPS next 5Y
-
EPS last 5Y
5.1%
Revenue last 5Y
5.22%
Revenue Q/Q
12.23%
EPS Q/Q
-4.3%
-
-
-
-
SMA20
-3.58%
SMA50
-2.56%
SMA100
1.55%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
16%
ROC
0.08%
Gross Margin
52%
Oper. Margin
41%
Profit Margin
32%
Payout
37%
Shs Outstand
4.49B
Shs Float
3.23B
-
-
-
-
Target Price
-
52W Range
63.5-71.0
52W High
-10.92%
52W Low
+0.4%
RSI
42.69
Rel Volume
-
Avg Volume
-
Volume
1.15M
Perf Week
-1.17%
Perf Month
0%
Perf Quarter
0.8%
Perf Half Y
-3.07%
-
-
-
-
Beta
0.731
-
-
Volatility
0.42%, 1.13%
Prev Close
-0.39%
Price
63.25
Change
0.8%
CPN-R.BK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.35 | 6.41 | 5.72 | 7.96 | 10.79 | |
Net income per share | 2.62 | 2.14 | 1.6 | 2.41 | 3.36 | |
Operating cash flow per share | 3.96 | 1.74 | 1.76 | 3.67 | 4.69 | |
Free cash flow per share | 3.03 | 1.57 | 1.64 | 3.42 | 4.41 | |
Cash per share | 0.68 | 2.06 | 1.35 | 1.37 | 1.13 | |
Book value per share | 16.07 | 15.39 | 16.35 | 18.22 | 20.6 | |
Tangible book value per share | 13.07 | 16.94 | 18.02 | 19.69 | 22.11 | |
Share holders equity per share | 16.07 | 15.39 | 16.35 | 18.22 | 20.6 | |
Interest debt per share | 7.75 | 21.01 | 29.04 | 29.26 | 18.45 | |
Market cap | 279.38B | 213.48B | 252.6B | 317.43B | 306.81B | |
Enterprise value | 311.35B | 298.35B | 377.51B | 442.8B | 430.11B | |
P/E ratio | 23.8 | 22.34 | 35.34 | 29.5 | 20.37 | |
Price to sales ratio | 7.46 | 7.45 | 9.88 | 8.92 | 6.35 | |
POCF ratio | 15.72 | 27.51 | 32.14 | 19.37 | 14.59 | |
PFCF ratio | 20.51 | 30.44 | 34.39 | 20.79 | 15.55 | |
P/B Ratio | 3.87 | 3.1 | 3.46 | 3.9 | 3.33 | |
PTB ratio | 3.87 | 3.1 | 3.46 | 3.9 | 3.33 | |
EV to sales | 8.31 | 10.41 | 14.76 | 12.45 | 8.9 | |
Enterprise value over EBITDA | 14.46 | 14.84 | 21.49 | 19.9 | 15.53 | |
EV to operating cash flow | 17.52 | 38.44 | 48.04 | 27.02 | 20.46 | |
EV to free cash flow | 22.86 | 42.54 | 51.39 | 29 | 21.8 | |
Earnings yield | 0.04 | 0.04 | 0.03 | 0.03 | 0.05 | |
Free cash flow yield | 0.05 | 0.03 | 0.03 | 0.05 | 0.06 | |
Debt to equity | 0.47 | 1.34 | 1.75 | 1.58 | 0.86 | |
Debt to assets | 0.2 | 0.42 | 0.49 | 0.47 | 0.28 | |
Net debt to EBITDA | 1.48 | 4.22 | 7.11 | 5.63 | 4.45 | |
Current ratio | 0.78 | 0.78 | 0.54 | 0.6 | 0.47 | |
Interest coverage | 18.63 | 6.54 | 5.7 | 6.38 | 5.98 | |
Income quality | 1.5 | 0.81 | 1.09 | 1.51 | 1.4 | |
Dividend Yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.43 | 0.38 | 0.44 | 0.25 | 0.34 | |
Sales general and administrative to revenue | 0.18 | 0.19 | 0.21 | 0.19 | 0.16 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.13 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.23 | -0.1 | -0.07 | -0.07 | -0.06 | |
Capex to revenue | -0.11 | -0.03 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -0.58 | -0.09 | -0.06 | -0.13 | -0.15 | |
Stock based compensation to revenue | -0.05 | -0.18 | -0.22 | -0.1 | -0.54 | |
Graham number | 30.75 | 27.2 | 24.25 | 31.41 | 39.48 | |
ROIC | 0.11 | 0.05 | 0.03 | 0.04 | 0.07 | |
Return on tangible assets | 0.08 | 0.04 | 0.03 | 0.04 | 0.05 | |
Graham Net | -17.49 | -28.34 | -36.84 | -37.14 | -32.87 | |
Working capital | -4.7B | -6.67B | -19.98B | -16.79B | -28.32B | |
Tangible asset value | 58.64B | 75.75B | 80.55B | 88.02B | 99.02B | |
Net current asset value | -73.09B | -120.76B | -157.83B | -157.83B | -153.75B | |
Invested capital | 0.47 | 1.34 | 1.75 | 1.58 | 0.86 | |
Average receivables | 4.45B | 5.3B | 6.51B | 6.43B | 15.24B | |
Average payables | 4.39B | 3.46B | 2.81B | 3.15B | 3.81B | |
Average inventory | 8.07B | 8.7B | 9.55B | 11.86B | 15.05B | |
Days sales outstanding | 48.35 | 71.67 | 105.53 | 55.97 | 189.12 | |
Days payables outstanding | 82.65 | 68.75 | 68.65 | 71.11 | 69.58 | |
Days of inventory on hand | 168.75 | 219.25 | 248.42 | 276.62 | 278.85 | |
Receivables turnover | 7.55 | 5.09 | 3.46 | 6.52 | 1.93 | |
Payables turnover | 4.42 | 5.31 | 5.32 | 5.13 | 5.25 | |
Inventory turnover | 2.16 | 1.66 | 1.47 | 1.32 | 1.31 | |
ROE | 0.16 | 0.14 | 0.1 | 0.13 | 0.16 | |
Capex per share | -0.93 | -0.17 | -0.11 | -0.25 | -0.29 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.28 | 2.24 | 2.43 | 2.66 | 2.98 | |
Net income per share | 0.63 | 0.73 | 0.82 | 0.93 | 0.89 | |
Operating cash flow per share | 0.86 | 1.05 | 1.12 | 1.3 | 1.23 | |
Free cash flow per share | 0.82 | 0.99 | 1.05 | 1.21 | 1.16 | |
Cash per share | 1.37 | 1.21 | 1.31 | 0.97 | 1.13 | |
Book value per share | 18.22 | 19.07 | 18.65 | 19.78 | 20.56 | |
Tangible book value per share | 19.69 | 20.62 | 20.2 | 21.33 | 22.06 | |
Share holders equity per share | 18.22 | 19.07 | 18.65 | 19.78 | 20.56 | |
Interest debt per share | 28.9 | 28.75 | 29.41 | 28.6 | 17.89 | |
Market cap | 317.43B | 305.69B | 292.84B | 283.04B | 307.43B | |
Enterprise value | 442.8B | 430.68B | 420.85B | 408.17B | 430.73B | |
P/E ratio | 28.28 | 23.54 | 19.91 | 17 | 19.33 | |
Price to sales ratio | 31.09 | 30.63 | 26.95 | 23.75 | 22.98 | |
POCF ratio | 82.77 | 65.65 | 58.7 | 48.61 | 55.79 | |
PFCF ratio | 86.39 | 69.43 | 62.57 | 52.38 | 59.1 | |
P/B Ratio | 3.9 | 3.6 | 3.51 | 3.2 | 3.33 | |
PTB ratio | 3.9 | 3.6 | 3.51 | 3.2 | 3.33 | |
EV to sales | 43.37 | 43.15 | 38.74 | 34.25 | 32.2 | |
Enterprise value over EBITDA | 80.44 | 68.37 | 61.57 | 54.4 | 58.67 | |
EV to operating cash flow | 115.46 | 92.49 | 84.36 | 70.1 | 78.17 | |
EV to free cash flow | 120.51 | 97.81 | 89.93 | 75.54 | 82.8 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Debt to equity | 1.58 | 1.5 | 1.57 | 1.44 | 0.86 | |
Debt to assets | 0.47 | 0.46 | 0.47 | 0.46 | 0.28 | |
Net debt to EBITDA | 22.77 | 19.84 | 18.73 | 16.68 | 16.8 | |
Current ratio | 0.6 | 0.51 | 0.52 | 0.44 | 0.47 | |
Interest coverage | 6.07 | 7.02 | 6.86 | 7.88 | 5.89 | |
Income quality | 1.35 | 1.42 | 1.34 | 1.38 | 1.39 | |
Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.4 | 0.01 | 0 | |
Sales general and administrative to revenue | 0.22 | 0.18 | 0.16 | 0.15 | 0.19 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0.01 | |
Capex to operating cash flow | -0.04 | -0.05 | -0.06 | -0.07 | -0.06 | |
Capex to revenue | -0.02 | -0.03 | -0.03 | -0.04 | -0.02 | |
Capex to depreciation | -0.07 | -0.12 | -0.14 | -0.19 | -0.14 | |
Stock based compensation to revenue | 0.08 | -0.07 | -0.24 | -0.18 | -0.58 | |
Graham number | 16.04 | 17.7 | 18.58 | 20.34 | 20.24 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -37.14 | -37.47 | -38 | -37.46 | -32.81 | |
Working capital | -16.79B | -23.22B | -24.01B | -29.74B | -28.32B | |
Tangible asset value | 88.02B | 91.69B | 90.31B | 95.43B | 99.02B | |
Net current asset value | -157.83B | -158.23B | -161.08B | -158.99B | -153.75B | |
Invested capital | 1.58 | 1.5 | 1.57 | 1.44 | 0.86 | |
Average receivables | 5.84B | 4.86B | 4.17B | 3.92B | 14.4B | |
Average payables | 2.31B | 2.31B | 1.2B | 1.25B | 2.65B | |
Average inventory | 13.04B | 14.12B | 15.09B | 15.51B | 15.92B | |
Days sales outstanding | 48.09 | 38.51 | 33.69 | 28.44 | 168.45 | |
Days payables outstanding | 62.65 | 20.88 | 22.18 | 18.64 | 64.57 | |
Days of inventory on hand | 243.7 | 275.95 | 266.22 | 240.63 | 258.74 | |
Receivables turnover | 1.87 | 2.34 | 2.67 | 3.16 | 0.53 | |
Payables turnover | 1.44 | 4.31 | 4.06 | 4.83 | 1.39 | |
Inventory turnover | 0.37 | 0.33 | 0.34 | 0.37 | 0.35 | |
ROE | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 | |
Capex per share | -0.04 | -0.06 | -0.07 | -0.09 | -0.07 |
CPN-R.BK Frequently Asked Questions
What is Central Pattana Public Company Limited stock symbol ?
Central Pattana Public Company Limited is a TH stock and trading under the symbol CPN-R.BK
What is Central Pattana Public Company Limited stock quote today ?
Central Pattana Public Company Limited stock price is $63.25 today.
Is Central Pattana Public Company Limited stock public?
Yes, Central Pattana Public Company Limited is a publicly traded company.